Steroid-related cancer types have the highest incidence among tumors. Scientists at the University of Göttingen developed new antagonists to a selected target receptor for the therapy of steroidal cancers, which potentially could also be used to treat malignant melanoma. In vivo proof of concept has been achieved.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
